ALEXION PHARMACEUTICALS, INC.·4

Dec 18, 5:12 PM ET

HANTSON LUDWIG 4

4 · ALEXION PHARMACEUTICALS, INC. · Filed Dec 18, 2020

Insider Transaction Report

Form 4
Period: 2020-12-16
HANTSON LUDWIG
DirectorCEO
Transactions
  • Award

    Common Stock, par value $.0001 per share

    2020-12-16+162,707353,365 total
  • Tax Payment

    Common Stock, par value $.0001 per share

    2020-12-16$157.96/sh13,059$2,062,800267,773 total
  • Tax Payment

    Common Stock, par value $.0001 per share

    2020-12-16$157.96/sh72,533$11,457,313280,832 total
Footnotes (3)
  • [F1]Shares acquired on vesting of Performance Stock Units previously granted on February 28, 2018 under the 2017 Stock Incentive Plan.
  • [F2]This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
  • [F3]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.

Documents

1 file
  • 4
    wf-form4_160832951612396.xmlPrimary

    FORM 4